

Ralph DeFronzo
Distinguished diabetes researcher and clinician whose groundbreaking work on insulin resistance has reshaped the understanding and treatment of type 2 diabetes. He is known for his pivotal role in bringing metformin to the U.S. and developing SGLT2 inhibitors.